Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T B Fitzpatrick

Showing results (121-130 of 178) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|February 25, 1982
Narrower margins for clinical stage I malignant melanomaC L Day, M C Mihm, A J Sober, et al.
The British Journal of Dermatology|September 1, 1982
Erythema in the primary lesion of superficial spreading melanoma is not of prognostic importanceD I McLean, R A Lew, A J Sober, et al.
Archives of Dermatology|November 1, 1980
Phototoxic reactions to photoactive drugs in patients treated with PUVAR S Stern, R A Kleinerman, J A Parrish, et al.
Cancer|June 1, 1984
Cigarette smoking and malignant melanoma. Prognostic implicationsH K Koh, A J Sober, C L Day, et al.
JAMA|December 4, 1987
Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individualsA R Rhodes, M A Weinstock, T B Fitzpatrick, et al.
Archives of Dermatology|June 1, 1972
Accuracy of dermatologic diagnosis by televisionR L Murphy, T B Fitzpatrick, H A Haynes, et al.
Cancer|January 1, 1979
On the prognostic importance of white depressed areas in the primary lesion of superficial spreading melanomaD I McLean, R A Lew, A J Sober, et al.
The British Journal of Dermatology|February 1, 1979
Comparison of PUVA and beta-carotene in the treatment of polymorphous light eruptionJ A Parrish, M J Le Vine, W L Morison, et al.
JAMA|May 20, 1974
Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyriaM M Mathews-Roth, U A Pathak, T B Fitzpatrick, et al.
Archives of Dermatology|September 1, 1977
Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseasesM M Mathews-Roth, M A Pathak, T B Fitzpatrick, et al.
Pageof 18

Showing results (121-130 of 178) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|February 25, 1982
Narrower margins for clinical stage I malignant melanomaC L Day, M C Mihm, A J Sober, et al.
The British Journal of Dermatology|September 1, 1982
Erythema in the primary lesion of superficial spreading melanoma is not of prognostic importanceD I McLean, R A Lew, A J Sober, et al.
Archives of Dermatology|November 1, 1980
Phototoxic reactions to photoactive drugs in patients treated with PUVAR S Stern, R A Kleinerman, J A Parrish, et al.
Cancer|June 1, 1984
Cigarette smoking and malignant melanoma. Prognostic implicationsH K Koh, A J Sober, C L Day, et al.
JAMA|December 4, 1987
Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individualsA R Rhodes, M A Weinstock, T B Fitzpatrick, et al.
Archives of Dermatology|June 1, 1972
Accuracy of dermatologic diagnosis by televisionR L Murphy, T B Fitzpatrick, H A Haynes, et al.
Cancer|January 1, 1979
On the prognostic importance of white depressed areas in the primary lesion of superficial spreading melanomaD I McLean, R A Lew, A J Sober, et al.
The British Journal of Dermatology|February 1, 1979
Comparison of PUVA and beta-carotene in the treatment of polymorphous light eruptionJ A Parrish, M J Le Vine, W L Morison, et al.
JAMA|May 20, 1974
Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyriaM M Mathews-Roth, U A Pathak, T B Fitzpatrick, et al.
Archives of Dermatology|September 1, 1977
Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseasesM M Mathews-Roth, M A Pathak, T B Fitzpatrick, et al.
Pageof 18